All Industries

First Phosphate provides update on the work to complete its Purified Phosphoric Acid Plant in Quebec

First Phosphate Corp

First Phosphate Corp CEO John Passalacqua joined Steve Darling from Proactive to announce a significant development for the company - the signing of a Joint Development Agreement with Integrals Power Limited of Milton Keynes, United Kingdom. This agreement marks a crucial step forward in First Phosphate's efforts to produce battery-grade iron III phosphate precursor for the lithium iron phosphate (LFP) battery industry outside of China. Passalacqua explained that the agreement outlines an initial phase of joint development focused on creating the technology necessary for producing the iron phosphate precursor for LFP cathode active material (CAM). The goal is to develop a scalable, low-cost, and environmentally compliant process for manufacturing battery-grade iron III phosphate. If successful, this technology could be combined with lithium carbonate or lithium hydroxide to produce LFP CAM. Furthermore, Passalacqua emphasized the collaborative nature of the agreement, with both parties committed to working together to bring the developed process into immediate large-scale production. Under the agreement, First Phosphate will provide the necessary raw materials for producing iron III phosphate, leveraging its phosphate concentrate and magnetite resources. This partnership with Integrals Power Limited represents a significant milestone for First Phosphate Corp as it strives to establish itself as a key player in the supply chain for lithium iron phosphate batteries. By developing innovative technologies and forging strategic partnerships, the company is well-positioned to capitalize on the growing demand for sustainable energy storage solutions. Contact Details Proactive Investors +1 604-688-8158 na-editorial@proactiveinvestors.com

February 20, 2024 11:01 AM Eastern Standard Time

Video

Everlodge Gains Momentum in Real Estate Sector as Interest in Avalanche (AVAX) and Cardano (ADA) Wanes

Everlodge

As the crypto market shows signs of retracement from its recent bullish momentum, top crypto coins such as Avalanche (AVAX) and Cardano (ADA) have witnessed a noticeable slowdown in their price trajectories. However, the same cannot be said for Everlodge (ELDG). Following the completion of its successful presale campaign, Everlodge has been drawing increased attention, particularly with its ongoing listing on tier-1 exchanges. This listing has continued to fuel purchasing activities for the cryptocurrency, setting it apart from the declining interest in AVAX and ADA alike. Everlodge (ELDG) Makes Strides in the Real Estate Niche With Growing Enthusiasm Among Investors Everlodge (ELDG) is slowly making a name for itself in the fast-growing multi-trillion-dollar real estate industry. The project stands out by leveraging innovative technology to digitize real-world assets (RWAs) into non-fungible tokens (NFTs). This groundbreaking approach enables potential investors to conveniently and affordably access co-ownership opportunities, with a minimum investment threshold as low as $100. The underlying concept behind Everlodge is to introduce fractional ownership in diverse real estate assets, ranging from vacation homes to hotels and luxurious villas. By doing so, the project disrupts the traditional norms of real estate investment, making it more accessible and flexible for individuals to participate in this lucrative market. Following a successful presale that propelled the ELDG token from $0.01 to $0.029, Everlodge is now well-positioned for even more exponential growth, further supported by its recent listing on Uniswap. With ambitious plans to expand its market presence through additional listings on tier-1 exchanges, Everlodge emerges as one of the top crypto coins for investment, offering long-term profitability. Meanwhile, the team has taken measures to ensure market stability and safeguard investors' interests by committing to lock the team tokens for two years and the liquidity pool for eight years, effectively mitigating potential market volatility. These steps solidify Everlodge's appeal as a promising cryptocurrency worth considering. Beyond its core offering of fractional ownership, Everlodge presents a range of enticing features. These include a dedicated loan platform, a reward club, discounted rental fees on co-owned properties, trade discounts, a marketplace, and a launchpad for aspiring property developers. These additional features further underscore the overall value proposition of Everlodge, making it an attractive choice for investors seeking exposure to the real estate market in a novel yet dynamic way. Avalanche (AVAX) Faces Uncertain Price Outlook as Bullish Momentum Depreciates After recently trading above a weekly high of $43, Avalanche (AVAX) price has made a sharp turn towards the downside. Notably, AVAX token has lost almost all its weekly gains as it makes its way back to the weekly entry point around $38. Currently trading above $39, with a weekly price range of $38.7 to $39.5, the Avalanche token has managed to retain some positivity, with a modest increase of just over 1.50% over the past week. In contrast, earlier in the week, the AVAX token surged by as much as 21%, soaring from $35.8 to $43.0. However, given the recent decline in AVAX token price, it remains uncertain whether the token can maintain stability around its initial weekly entry point or if the ongoing dip will lead to further declines in the near future. Cardano (ADA) Faces Uncertainties As Price Fluctuation Looms Cardano (ADA) is also experiencing price fluctuations, although it has not suffered significant losses. The weekly price chart for ADA still shows a nearly 10% increase. However, when compared to its peak price of $0.61, which represented a gain of over 15% at the time, it is evident that ADA is struggling to maintain stability. Currently trading above the $0.58 level, with a weekly price range of $0.53 to $0.59, the ADA price demonstrates relative stability while continuing on a reversal trend. Looking ahead, Everlodge presents more promising prospects compared to several other top crypto coins as it prepares to list on additional top-tier exchanges. This not only provides potential investors with an edge against market fluctuations but also positions Everlodge in a more lucrative landscape compared to tokens like AVAX and ADA. For more information about Everlodge (ELDG) please visit their website. Everlodge provides you with a seamless approach to fractional investing in vacation rentals, eliminating the complexities associated with traditional real estate investment. Our innovative platform revolutionizes the way people invest in second homes. Disclaimer: Digital currencies may be unregulated in your jurisdiction. The value of digital currencies may go down as well as up. Profits may be subject to capital gains or other taxes applicable in your jurisdiction. Contact Details Brett admin@everlodge.io Company Website https://everlodge.io/

February 20, 2024 10:00 AM Central Standard Time

Image

Standard Uranium reached agreement to option its Atlantic Project in the Athabasca Basin

Standard Uranium Ltd

Standard Uranium CEO Jon Bey joined Steve Darling from Proactive to unveil a significant development for the company: the signing of a term sheet with ATCO Mining, enabling them to acquire a seventy-five percent interest in the 3,061-hectare Atlantic Project situated in the eastern Athabasca Basin. This marks the company's fourth option agreement and positions Standard Uranium as the operator of the project. With over thirty million dollars committed to exploration programs over the next three years and nine million dollars dedicated to exploration in 2024, Standard Uranium is poised for significant advancement. In addition to this milestone, Bey disclosed that the company has made another strategic move through the acquisition of the Harrison uranium exploration project in the southwest Athabasca Basin region of Northern Saskatchewan. Through staking, the Ascent project has been expanded by 3,728 hectares, effectively doubling its size. This expansion brings the company's ownership interests to eleven exploration properties, totaling over 209,867 acres across the uranium-rich Athabasca Basin. Notably, the Harrison project presents a compelling opportunity as it has never undergone drill testing, offering Standard Uranium additional exploration exposure in the southwest Athabasca uranium district. These developments underscore Standard Uranium's strategic focus on expanding its exploration portfolio and advancing its presence in key uranium-rich regions. With a robust exploration budget and an expanded project portfolio, the company is well-positioned to capitalize on opportunities in the uranium market. Stay tuned for further updates as Standard Uranium continues its exploration efforts and seeks to unlock significant value for its stakeholders in the dynamic uranium sector. Contact Details Proactive Canada +1 604-688-8158 action@proactiveinvestors.com

February 20, 2024 10:56 AM Eastern Standard Time

Video

Volta Metals assay results from drilling at Falcon West shows high-grade Lithium Zones

Volta Metals Ltd

Volta Metals CEO Kerem Usenmez joined Steve Darling from Proactive to announce the release of assay results from 11 drill holes completed during the inaugural drill program at the Falcon West Lithium Property, situated in northwestern Ontario, Canada. The assay results revealed the presence of near-surface spodumene-albite pegmatite-hosted lithium, cesium, and tantalum mineralization, with potential for expansion. Usenmez explains that the initial drilling was strategically designed to test the five spodumene-bearing pegmatites identified during Volta's 2023 exploration program, which covered a small section of the vast 13km² property. Remarkably, all 11 boreholes successfully intercepted mineralization in five known pegmatites, with hole FW23-07 encountering blind pegmatite from 47.4m to 59.1m, before concluding at 60.1m depth. The success of the drilling campaign underscores the significant potential of the Falcon West Lithium Project. The data obtained will empower Volta's exploration team to enhance their understanding of the structural orientations of the pegmatites and refine drill-hole design for the upcoming 2024 exploration program. Furthermore, the high-grade lithium results, coupled with strongly anomalous cesium and tantalum, indicate the presence of a substantial LCT mineralized system within the Falcon West Project. Currently, the company is in the final stages of finalizing its 2024 exploration program, which will encompass diamond drilling, mechanized trenching, and additional geochemical sampling. This comprehensive approach underscores Volta Metals' commitment to advancing exploration efforts and unlocking the full potential of the Falcon West Lithium Project. Contact Details Proactive United States +1 347-449-0879 action@proactiveinvestors.com

February 20, 2024 10:51 AM Eastern Standard Time

Video

REEP Equity to Host Webinar About Multifamily Trends & Strategies for 2024

REEP Equity

Real Estate Equity Partners ( REEP Equity ) announced “ Unraveling the Multifamily Market: Trends & Strategies for 2024,” a live webinar that will take place on February 29, 2024. Anyone curious about investing in multifamily real estate in Texas is invited to register for the free event and tune in at 7:00 p.m. CST to learn from REEP Equity founders Jacob and Arleen Garza, as well as special guest Mark Brandenburg, Senior Managing Director at JLL Capital Markets. Those with questions about the multifamily market, seeking emerging investment opportunities in Texas, or those hoping to better understand fluctuating interest and cap rates are invited to attend. Webinar attendees can expect to learn the following: The benefits of multifamily investing with a trusted operator The economic forces that drive the Texas multifamily market and how Texas differs from the national market Owner strategies for buying and financing deals in the current market Market dynamics and how the ever-shifting trends can inform and help your investment strategies “There is so much noise in the media about multifamily. Many are unsure what to believe or who to trust. We’re excited to pull back the curtain for curious investors and share our thoughts and insights to help provide clarity,” said Jacob Garza, Founder of REEP Equity. “We often get asked, ‘Is multifamily in Texas a good investment? What great opportunities are you seeing?’ and ‘What strategies do you recommend for the best returns?’ We’ll answer these questions and more on February 29,” said Arleen Garza, Founder of REEP Equity. REEP Equity was founded in 2012 by Jacob and Arleen Garza, who are experts in acquiring multifamily properties in Texas that are underperforming but nevertheless generate income. Since its founding, REEP Equity has bought, sold, and managed $720M worth of multifamily assets across San Antonio, Houston, and Austin. The company has taken nine properties full cycle, with an average historical investor return of 2.17 x equity multiple, an average of 24% IRR, and 34% AAR. Its current portfolio includes 23 properties with a total of 4,171 units. Mark Brandenburg is a Senior Managing Director in the Dallas office of JLL Capital Markets, Americas. He has been involved in commercial real estate since 2000, with his primary area of responsibility being the capitalization of commercial real estate, including multi-housing, office, retail, industrial, mixed-use, hotels, seniors housing, and self-storage. Mark has facilitated structured finance solutions in conventional permanent financings, joint ventures, mezzanine debt, bridge loans, and construction financing. Over his time with JLL, Mark’s direct transactional experience exceeds $3.5 billion. The webinar is free to attend. Learn more and save your spot here. To learn more about REEP Equity, visit Reepequity.com. To learn more about JLL Capital Markets, visit us.jll.com. About Real Estate Equity Partners Real Estate Equity Partners (REEP Equity) is focused on acquiring underperforming, income-producing, multifamily investment opportunities in Texas. Headquartered in San Antonio, REEP Equity is vertically integrated with its in-house management company, REEP Residential, and this unique setup allows the two enterprises to work together, ensuring that the entire acquisition process is effectively managed, thereby creating value for investors while improving tenants' lives. Since its establishment, REEP Equity has bought, sold, and managed 5,500+ units, taking nine properties full cycle. About JLL Capital Markets For over 200 years, JLL Capital Markets (NYSE: JLL), a leading global commercial real estate and investment management company, has helped clients buy, build, occupy, manage, and invest in a variety of commercial, industrial, hotel, residential and retail properties. A Fortune 500 company with annual revenue of $20.9 billion and operations in over 80 countries around the world, its more than 103,000 employees bring the power of a global platform combined with local expertise. Driven by the company’s purpose to shape the future of real estate for a better world, they help their clients, people, and communities SEE A BRIGHTER WAY SM. Contact Details Ilissa Goldenberg +1 973-769-6108 ilissa@rprfirm.com Company Website https://reepequity.com/

February 20, 2024 10:50 AM Eastern Standard Time

Elutia's CanGarooRM: Pioneering Drug-Eluting Biologic for Secure Medical Implants

Elutia Inc.

Elutia CEO Randy Mills joined Steve Darling from Proactive to discuss the company's groundbreaking product, CanGarooRM, a drug-eluting biologic designed to safeguard implanted medical devices such as pacemakers. Founded by Mills and Kevin Rakin, both esteemed veterans in the biotech industry, Elutia aims to revolutionize healthcare by combining regenerative medicine with localized drug delivery. Mills shed light on CanGarooRM's unique formulation, which includes antibiotics to prevent infections and device migration, ultimately enhancing patient safety. With the FDA accepting their filing in December, Elutia is optimistic about receiving favorable results in the second quarter of this year. If approved, CanGarooRM has the potential to capture a significant share of the market, estimated to exceed $500 million. Mills further elaborated that Elutia has completed product development and is poised to commence commercial production by the late second quarter. A soft launch is planned for the third quarter, followed by full-scale deployment by the fourth quarter of this year. This strategic timeline positions Elutia for substantial growth pending regulatory approval, with CanGarooRM poised to address critical needs in the healthcare industry and improve patient outcomes. In summary, the interview underscored Elutia's promising trajectory and the transformative potential of CanGarooRM in enhancing medical device safety. With a strong foundation in regenerative medicine and localized drug delivery, Elutia is poised to make a significant impact in healthcare innovation, driving positive change and improving patient care globally. Contact Details Proactive North America Proactive North America +1 604-688-8158 NA-editorial@proactiveinvestors.com

February 20, 2024 10:37 AM Eastern Standard Time

Video

Hive Digital sees 146% increase in Gross Operating Margins as company releases Q3 earnings report

HIVE Digital Technologies

Hive Digital Technologies CEO Aydin Kilic joined Steve Darling from Proactive to announce the company's earnings report for the third quarter. Kilic revealed that the company achieved remarkable revenue of $30.1 million during this quarter, primarily attributed to mining 830 Bitcoin. Notably, the Gross Operating Margin stood at an impressive 38%, translating to $11.3 million in income from digital currency mining operations. Kilic highlighted that these figures represent a significant 146% increase in Gross Operating Margin compared to the previous quarter. He attributed the stronger Bitcoin mining economics to the rally in Bitcoin prices, potentially fuelled by the news surrounding Bitcoin ETFs in the United States and the subsequent SEC approval on January 10, 2024. In addition to revenue from Bitcoin mining, the company realized $0.9 million in revenue during the quarter from its GPU-powered High Performance Computing business unit. This segment leverages the company's GPUs for various AI computations, including inference and fine-tuning of large language models. Overall, these impressive financial results underscore Hive Digital Technologies' strong performance in the cryptocurrency mining sector and its strategic diversification into other high-growth areas such as AI computation. Contact Details Proactive North America Proactive North America +1 604-688-8158 NA-editorial@proactiveinvestors.com

February 20, 2024 10:32 AM Eastern Standard Time

Video

Simply Solventless Concentrates announces new VP as company plans 2024 products launch

Simply Solventless Concentrates

Simply Solventless Concentrates CEO Jeff Swainson joins Steve Darling from Proactive to share exciting updates regarding the company's upcoming activities. Simply Solventless Concentrates anticipates a busy month ahead, with approximately $1.25 million in purchase orders lined up from Alberta and Ontario. Additionally, the company is set to launch six third-party branded products in Alberta and one in Ontario, further expanding its market presence. Swainson underscored the importance of strategic leadership in supporting the company's growth trajectory. To this end, Simply Solventless Concentrates announced the appointment of Jeff Lawrence to the position of Vice President, Marketing & Sales. Lawrence brings over 30 years of experience in industrial and consumer packaged goods, including five years in the cannabis industry. With a proven track record of driving sales growth and propelling startups through strategic development, team building, and effective leadership, Lawrence is poised to make a significant impact on the company's sales and marketing initiatives. Swainson highlighted Lawrence's previous role as National Director of Sales at Dycar Pharmaceuticals, where he played a key role in overseeing the launch of four brands and scaling store listings from 70 to over 2,200 across five provinces. Lawrence's extensive experience and leadership acumen make him a valuable addition to the Simply Solventless Concentrates team, positioning the company for continued success and expansion in the competitive cannabis market. With a robust pipeline of purchase orders and new product launches on the horizon, Simply Solventless Concentrates is primed for growth under Lawrence's leadership. Stay tuned for further updates as the company continues to execute its strategic initiatives and capitalize on emerging opportunities in the cannabis industry. Contact Details Proactive North America Proactive North America +1 604-688-8158 NA-editorial@proactiveinvestors.com

February 20, 2024 10:29 AM Eastern Standard Time

Video

CervoMed appoints drug development veteran Dr. Joshua Boger as Chairman of the Board

CervoMed

CervoMed Inc CEO John Alam joined Steve Darling from Proactive to announce a significant addition to the company's leadership team. CervoMed has appointed Joshua Boger to its Board of Directors as Chair, leveraging his wealth of experience in drug development and biopharmaceutical leadership to drive the company's strategic initiatives forward. Dr. Boger is a seasoned industry veteran with over 40 years of experience, renowned for his innovative approach to science and proven track record as a business executive. Currently serving as Executive Chairman of Alkeus Pharmaceuticals, Dr. Boger brings invaluable insights and expertise to CervoMed. Alam elaborated on the significance of Dr. Boger's appointment and the pivotal phase the company is entering, with topline data from the RewinD-LB Phase 2b clinical trial evaluating neflamapimod in dementia with Lewy bodies (DLB) expected in the second half of 2024. Neflamapimod, an investigational orally administered small molecule brain penetrant that inhibits p38MAP kinase alpha, holds immense promise in addressing synaptic dysfunction, particularly in the basal forebrain cholinergic system, which is most impacted in DLB. Drawing from preclinical studies and clinical trials involving over 300 participants, Alam highlighted neflamapimod's favorable safety profile and its significant impact on dementia severity as demonstrated in the AscenD-LB Phase 2a clinical study. These promising results underscore the potential of neflamapimod to address the unmet medical needs in DLB and pave the way for transformative treatment options. The appointment of Dr. Boger and the advancements in CervoMed's clinical trials signify a significant milestone in the company's mission to develop innovative therapies for neurodegenerative diseases. With a visionary leadership team and a promising pipeline of treatments, CervoMed is poised to make a meaningful impact on the lives of patients and caregivers affected by DLB and related conditions. Stay tuned for further updates as CervoMed continues its journey towards advancing neurological healthcare. Contact Details Proactive North America Proactive North America +1 604-688-8158 NA-editorial@proactiveinvestors.com

February 20, 2024 10:22 AM Eastern Standard Time

Video

1 ... 434 435 436 437 438 ... 3788